Lyle R Dauner, RPHA in Mankato, KS - Pharmacist

Lyle R Dauner, RPHA is a Pharmacist based in Mankato, Kansas. Lyle R Dauner is licensed to practice in Kansas (license number 1-09661) and his current practice location is 125 N Commercial St, Mankato, Kansas. He can be reached at his office (for appointments etc.) via phone at (785) 378-3183.

NPI number for Lyle R Dauner is 1285779371 and his current mailing address is 125 N Commercial St, Po Box 266, Mankato, Kansas. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1285779371.

Contact Information

	Lyle R Dauner, RPHA
	125 N Commercial St, Mankato, KS 66956-2206
	(785) 378-3183
	(785) 378-3809

Healthcare Provider's Profile

Full Name	Lyle R Dauner
Gender	Male
Speciality	Pharmacist
Location	125 N Commercial St, Mankato, Kansas
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1285779371
Provider Enumeration Date: 02/20/2007
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Lyle R Dauner such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1285779371	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	1-09661 (Kansas)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Lyle R Dauner is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Lyle R Dauner, RPHA 125 N Commercial St, Po Box 266, Mankato, KS 66956-2206 Ph: (785) 378-3183	Lyle R Dauner, RPHA 125 N Commercial St, Mankato, KS 66956-2206 Ph: (785) 378-3183

News Archive

New actinic keratoses data presented at the 15th World Congress of Cancers of the Skin

New data from the international FIELD Study Repeat presented today at the 15th World Congress of Cancers of the Skin (WCCS) in Edinburgh, Scotland, demonstrate initial treatment with Picato® (ingenol mebutate gel) 0.015% is efficacious in treating actinic keratoses (AK) and, when followed by a repeat cycle for persistent and newly emerging AKs, this efficacy is further increased.1 The data also confirm two treatment cycles of Picato® are well tolerated by patients.2

AAHP updates about the sale of homeopathic medicines to prevent the flu

Recent news articles regarding the scarcity of the "flu shot" (or influenza inoculations) have been widespread. The shortage of the material, due to manufacturing and regulatory issues, has led to increased interest in homeopathic Influenzinum.

Champagne improves blood flow and reduces risk of cardiovascular diseases

Research from the University of Reading suggests that two glasses of Champagne a day may be good for your heart and circulation. The researchers have found that drinking Champagne wine daily in moderate amounts causes improvements in the way blood vessels function.

U.N. SG Ban announces 'Zero Hunger Challenge' in message to Rio+20 summit

In a video message addressing the Rio+20 summit in Rio de Janeiro, Brazil, on Thursday, U.N. Secretary-General Ban Ki-moon "announced a 'Zero Hunger Challenge' to rid the world of malnutrition," Bloomberg News reports.

Italy grapples with the largest coronavirus outbreak in Europe

In just a matter of days, Italy has reported an increasing number of cases linked to the novel coronavirus that is spreading rapidly across the globe. The coronavirus disease (COVID-19) has emerged in China late in December 2019 and has so far reached 30 countries.

Lyle R Dauner, RPHA - Pharmacist in Mankato, KS